What is the dosing range for Gonadorelin?

Gonadorelin is typically dosed at 50mcg (low), 100mcg (moderate), or 200mcg (high) mcg, administered 2–3x per week subcutaneous. These ranges are aggregated from preclinical research and community protocols — not medical dosing guidance.

What are the reported side effects of Gonadorelin?

Reported side effects of Gonadorelin include: Injection site reactions, Headache, Nausea, Flushing, Ovarian hyperstimulation (in women — dose-dependent), Desensitization with high-frequency dosing.

Performance

Gonadorelin

Also known as: GnRH, gonadotropin-releasing hormone, Factrel, Lutrepulse

Share:Share on Reddit

Gonadorelin is a prescription compound in many jurisdictions. For research and informational purposes only.

📚 Content aggregated from:2 peer-reviewed sources·r/Peptides community·PubMed / NCBI

Overview

Synthetic form of endogenous gonadotropin-releasing hormone (GnRH) that stimulates LH and FSH release from the anterior pituitary. Used in TRT protocols to maintain testicular function and prevent atrophy during exogenous testosterone administration. Preserves spermatogenesis and endogenous testosterone production capacity.

Research Summary

Gonadorelin directly binds GnRH receptors in the anterior pituitary to trigger LH and FSH secretion, which in turn stimulates Leydig cells for testosterone production and maintains spermatogenesis. Used as a TRT adjunct, pulsatile gonadorelin administration mimics natural hypothalamic GnRH to prevent testicular suppression associated with exogenous androgen use.

Dosing Range

low

50mcg

moderate

100mcg

high

200mcg

Units: mcg · Frequency: 2–3x per week subcutaneous

Dosing ranges are aggregated from preclinical research and community protocols. Not medical dosing guidance.

Administration Routes

Subcutaneous injectionIntranasal (pulsatile delivery)

Reconstitution Notes

Reconstitute with sterile or bacteriostatic water. Target concentration: 100mcg/mL. Stable 14–28 days refrigerated after reconstitution.

Step-by-step reconstitution guide →

Supplies you'll need

Insulin Syringes (U-100)Reconstitution Needles Lambda BAC Water Alcohol Prep Pads

Affiliate links — Research Stack may earn a small commission at no extra cost to you.

Reported Side Effects

Injection site reactions
Headache
Nausea
Flushing
Ovarian hyperstimulation (in women — dose-dependent)
Desensitization with high-frequency dosing

Research Papers

2 peer-reviewed sources

Pulsatile administration of gonadotropin-releasing hormone in hypothalamic amenorrhea

Journal of Clinical Endocrinology & Metabolism1983

Gonadorelin in male hypogonadism and TRT protocols

European Journal of Endocrinology2009

Community Experiences

Aggregated from public forums. Anecdotal — not clinical evidence.

r/Testosterone

Community reports on gonadorelin use during TRT for testicular maintenance and fertility preservation.

View original thread

r/Peptides

Reconstitution protocols and dosing schedules for gonadorelin in TRT contexts.

View original thread

Overview

Gonadorelin is the synthetic version of the endogenous decapeptide gonadotropin-releasing hormone (GnRH), produced naturally by the hypothalamus. It is secreted in a pulsatile fashion to drive the hypothalamic-pituitary-gonadal (HPG) axis. Continuous stimulation paradoxically causes desensitization — pulsatile administration is physiologically essential.

In clinical practice, gonadorelin's primary research application is as a TRT adjunct: men on exogenous testosterone experience profound suppression of their HPG axis, leading to testicular atrophy, loss of intratesticular testosterone, and infertility. Gonadorelin restores pulsatile LH/FSH signaling to maintain testicular function.

Mechanism

GnRH receptor binding: Gonadorelin binds GnRH receptors (GnRHR) on gonadotroph cells in the anterior pituitary
LH and FSH release: Receptor activation triggers exocytosis of LH and FSH into portal circulation
Leydig cell stimulation: LH reaches testicular Leydig cells → stimulates intratesticular testosterone synthesis
Spermatogenesis: FSH supports Sertoli cells for sperm maturation
Pulsatile dependence: Continuous exposure causes GnRHR downregulation (see triptorelin); 2–3x/week dosing mimics natural pulsatile pattern

Gonadorelin vs. hCG

| Parameter | Gonadorelin | hCG | |-----------|-------------|-----| | Mechanism | GnRH receptor agonist | LH receptor agonist | | Route | SC/intranasal | SC/IM | | LH mimicry | Indirect (via pituitary) | Direct (bypasses pituitary) | | FSH effect | Yes (via pituitary) | No | | Availability | Compounding pharmacy | Prescription injectable | | Desensitization risk | Low (pulsatile) | Low |

Use in TRT Protocols

A common protocol combines gonadorelin 100–200mcg 2–3x/week with a testosterone ester. The goal is to prevent complete intratesticular testosterone suppression and maintain testicular volume. This is relevant for men who wish to preserve fertility or who plan to eventually discontinue TRT.

Dosing Considerations

Frequency matters more than dose for gonadorelin. The 2–3x/week schedule maintains pulsatile stimulation without causing receptor downregulation. Daily dosing at low concentrations may also be used via insulin pump-style infusion in fertility protocols.